Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR

American Journal of Pathology

Volumn 166, Issue 2, 2005, Pages 533-543

  Pedraza, Carlos E ^a   Podlesniy, Petar ^a   Vidal, Noemí ^b   Arévalo, Juan Carlos ^c   Lee, Ramee ^d   Hempstead, Barbara ^d   Ferrer, Isidre ^b   Iglesias, Montse ^a   Espinet, Carme ^a  

^a UNIVERSITY OF LLEIDA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIN; PROTEIN P75;

ALZHEIMER DISEASE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL INTERACTION; CHROMATOGRAPHY; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; RAT; SYMPATHETIC NERVE CELL; WESTERN BLOTTING;

EID: 13244288122     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62275-4     Document Type: Article

References (45)

1. Duychaerts CH, Dickson DW: Neuropathology of Alzheimer's disease. Neurodegeneration: the molecular pathology of dementia and movement disorders. Edited by Dickson DW. Basel, ISN Neuropathology Press, 2003, pp 47-65
2. Selkoe DJ: Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999, 399:A23-A31
3. Morishima Y, Gotoh Y, Zieg J, Barrett T, Takano H, Flavell R, Davis RJ, Shirasaki Y, Greenberg ME: Beta amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J Neurosci 2001, 21:7551-7560
4. Troy CM, Rabacchi SA, Xu Z, Maroney AC, Connors TJ, Shelanski ML, Greene LA: Beta amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation. J Neurochem 2001, 77:157-164
5. Tsukamoto E, Hashimoto Y, Kanekura K, Niikura T, Aiso S, Nishimoto I: Characterization of the toxic mechanism triggered by Alzheimer's amyloid-beta peptides via p75 neurotrophin receptor in neuronal hybrid cells. J Neurosci Res 2003, 73:627-636
6. Yaar M Zhai S, Pilch PF, Doyle SM, Eisenhauer PB, Fine RE, Gilchrest BA: Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis: a possible mechanism for Alzheimer's disease. J Clin Invest 1997, 100:2333-2340
7. Yaar M Zhai S, Fine RE, Eisenhauer PB, Arble BL, Stewart KB, Gilchrest BA: Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J Biol Chem 2002, 277:7720-7725
8. Troy CM, Rabacchi SA, Friedman WJ, Frappier TF, Brown K, Shelanski ML: Caspase-2 mediates neuronal cell death induced by beta-amyloid. J Neurosci 2000, 20:1386-1392
9. Friedman WJ: Neurotrophins induce death of hippocampal neurons via the p75 receptor. J Neurosci 2000, 20:6340-6346
10. Naumann T, Casademunt E, Hollerbach E, Hofmann J, Dechant G, Frotscher M, Barde YA: Complete deletion of the neurotrophin receptor p75NTR leads to long-lasting increases in the number of basal forebrain cholinergic neurons. J Neurosci 2002, 22:2409-2418
11. Frade JM, Barde YA: Genetic evidence for cell death mediated by nerve growth factor and the neurotrophin receptor p75 in the developing mouse retina and spinal cord. Development 1999, 126:683-690
12. Beattie MS, Harrington AW, Lee R, Kim JY, Boyce SL, Longo FM, Bresnahan JC, Hempstead BL, Yoon SO: Pro-NGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 2002, 36:375-386
13. Yoon SO, Casaccia-Bonnefil P, Carter B, Chao MV: Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J Neurosci 1998, 18:3273-3281
14. Lee R, Kermani P, Teng KK, Hempstead BL: Regulation of cell survival by secreted proneurotrophins. Science 2001, 294:1945-1948
15. Chao MV, Bothwell M: Neurotrophins: to cleave or not to cleave. Neuron 2002, 33:9-12
16. Fahnestock M, Michalski B, Xu B, Coughlin MD: The precursor pronerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease. Mol Cell Neurosci 2001, 18:210-220
17. Yiangou Y, Facer P, Sinicropi DV, Boucher TJ, Bennett DL, McMahon SB, Anand P: Molecular forms of NGF in human and rat neuropathic tissues: decreased NGF precursor-like immunoreactivity in human diabetic skin. J Peripher Nerv Syst 2002, 7:190-197
18. Reinshagen M, Geerling I, Eysselein VE, Adler G, Huff K, Moore GP, Lakshmanan J: Commercial recombinant human beta-nerve growth factor and adult rat dorsal root ganglia contain an identical molecular species of nerve growth factor prohormone. J Neurochem 2000, 74:2127-2133
19. Mowla SJ, Pareek S, Farhadi HF, Petrecca K, Fawcett JP, Seidah NG, Morris SJ, Sossin WS, Murphy RA: Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons. J Neurosc 1999, 19:2069-2080
20. Edwards RH, Selby MJ, Garcia PD, Rutter WJ: Processing of the native nerve growth factor precursor to form biologically active nerve growth factor. J Biol Chem 1988, 263:6810-6815
21. Ullrich A, Gray A, Berman C, Dull TJ: Human beta-nerve growth factor gene sequence is highly homologous to that of mouse. Nature 1983, 303:821-825
22. Edwards RH, Selby MJ, Rutter WJ: Differential RNA splicing predicts two distinct nerve growth factor precursors. Nature 1986, 319:784-787
23. Peng S, Wuu J, Mufson EJ, Fahnestock M: Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J Neuropathol Exp Neurol 2004, 63:641-649
24. Braak H, Braak E: Sequence of Alzheimer's disease-related pathology. Cerebral Cortex: Neurodegenerative and Age-Related Changes in Structure and Function of Cerebral Cortex. Edited by Peters A, Morrison JH. New York, Boston, Dordrecht, London, Moscow, Kluwer Academic/Plenum Press Publishers, 1999, vol 14:475-512
25. Ferrer I, Barrachina M, Puig B: Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains. Acta Neuropathol (Berl) 2002, 104:658-664
26. Longo FM, Woo JE, Mobley WC: Purification of nerve growth factor. Nerve Growth Factors. Edited by Rush RA. Chicago, John Wiley and Sons Ltd, 1989, pp 3-30
27. Edwards RH, Selby MJ, Mobley WC, Weinrich SL, Hruby DE, Rutter WJ: Processing and secretion of nerve growth factor: expression in mammalian cells with a vaccinia virus vector. Mol Cell Biol 1988, 8:2456-2464
28. Greene LA Tischler AS: Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 1976, 73:2424-2428
29. Burstein DE, Blumberg PM, Greene LA: Nerve growth factor-induced neuronal differentiation of PC12 pheochromocytoma cells: lack of inhibition by a tumor promoter. Brain Res Rev 1982, 247:115-119
30. Rattenholl A, Lilie H, Grossmann A, Stern A, Schwarz E, Rudolph R: The pro-sequence facilitates folding of human nerve growth factor from Escherichia coli inclusion bodies. Eur J Biochem 2001, 268:3296-3303
31. Ma Y, Campenot RB, Miller FD: Concentration-dependent regulation of neuronal gene expression by nerve growth factor. J Cell Biol 1992, 117:135-141
32. Mischel PS, Smith SG, Vining ER, Valletta JS, Mobley WC, Reichardt LF: The extracellular domain of p75NTR is necessary to inhibit neurotrophin-3 signaling through TrkA. J Biol Chem 2001, 276:11294-11301
33. Hempstead BL: The many faces of p75NTR. Curr Opin Neurobiol 2002, 12:260-267
34. Roux PP, Barker PA: Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol 2002, 67:203-233
35. Fahnestock M, Yu G, Michalski B, Mathew S, Colquhoun A, Ross G, Coulghlin D: The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature growth factor. J Neurochem 2004, 89:581-592
36. Harrington AW, Leiner B, Blechschmitt C, Arevalo JC, Lee R, Mörl K, Meyer M, Hempstead BL, Yoon SO, Giehl KM: From the cover: secreted proNGF is a pathophysiological death-inducing ligand after adult CNS injury. Proc Natl Acad Sci USA 2004, 101:6226-6230
37. Seidah NG, Benjannet S, Pareek S, Savaria D, Hamelin J, Goulet B, Laliberte J, Lazure C, Chretien M, Murphy RA: Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases. Biochem J 1996, 314:951-960
38. Ledesma M, Da Silva JS, Crassaerts K, Delacourte A, De Strooper B, Dotti CG: Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains. EMBO Rep 2000, 1:530-535
39. Saez-Valero J, Mok SS, Small DH: An unusually glycosylated form of acetylcholinesterase is a CSF biomarker for Alzheimer's disease. Acta Neurol Scand Suppl 2000, 176:49-52
40. Fodero LR, Saez-Valero J, McLean CA, Martins RN, Beyreuther K, Masters CL, Robertson TA, Small DH: Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition. J Neurochem 2002, 81:441-448
41. Buée L, Bussière T, Buée-Cherrer V, Delacourte A, Hof PR: Tau protein isoforms, phosphorylation, and role in neurodegenerative disorders. Brain Res Rev 2000, 33:95-130
42. Ferrer I, Marin C, Rey MJ, Ribalta T, Goutan E, Blanco R, Tolosa E, Martí E: BDNF and full-length and truncated TrkB expression in Alzheimer disease: implications in therapeutic strategies. J Neuropathol Exp Neurol 1999, 58:729-739
43. Srinivasan B, Roque CH, Hempstead BL, Al-Ubaidi M, Roque RS: Microglia-derived pronerve growth factor promotes photoreceptor cell death via p75 neurotrophin receptor. J Biol Chem 2004, 279: 41839-41845
44. Lakshmanan J, Beattie GM, Hayek A, Burns C, Fisher DA: Biological actions of 53 kDa nerve growth factor as studied by a blot and culture technique. Neurosci Lett 1989, 99:263-267
45. Perini G, Della-Bianca V, Politi V, Della Valle G, Dal-Pra I, Rossi F, Armato U: Role of neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines. J Exp Med 2002, 7:907-918